Literature DB >> 2400996

Differential spectrum of expression of neural cell adhesion molecule isoforms and L1 adhesion molecules on human neuroectodermal tumors.

D F Figarella-Branger1, P L Durbec, G N Rougon.   

Abstract

A series of four medulloblastomas, seven neuroblastomas (Nb), two ependymomas, and three gliomas, human neuroectodermal tumors, were screened for their expression of adhesion molecules L1, carcinoembryonic antigen, neural cell adhesion molecule isoforms (N-CAM) and HNK1 epitope by Western blotting and double immunofluorescence labeling. All seven neuroblastomas, whatever their differentiated state, expressed L1, a neural cell surface developmental antigen, whereas all other tumors tested were negative. All tumors expressed N-CAM; however, a large diversity was observed among the isoforms. Low sialylated N-CAM 140 was present, with different intensity, in ependymomas and astrocytomas. High sialylated isoforms were detected by a monoclonal antibody (anti-MenB) specifically recognizing high polymers of alpha 2-8 linked neuraminic acid. They were expressed in all medulloblastomas studied (4 of 4), and in 4 of 7 Nbs examined. Negative cases corresponded to tumors having undergone chemotherapeutic treatment or to ganglioneuroma. The interconversion from high to low sialylated forms might reflect changes which are critical for the conversion of Nbs into benign ganglioneuromas. HNK1 epitope was expressed on a large diversity of molecules by nearly all tumors except two Nbs which were also negative with anti-MenB antibody. This simultaneous loss of carbohydrate epitopes could correlate with higher maturation states of the tumors. None of the tumors expressed carcinoembryonic antigen. Therefore, anti-L1 and anti-MenB antibodies define differentiation-related antigens that could differentiate between Nbs and other tumors and may prove helpful in diagnosis and understanding of the biological nature of neuroectodermal tumors. An immunodot assay was set up and allowed to titrate the presence of polysialic acid units in cerebrospinal fluid from patients presenting meningeal spread of medulloblastomas. It could help to assess metastasis and to monitor the effects of chemotherapeutic treatment on polysialylated N-CAM positive tumors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2400996

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

1.  Paucity of retinoic acid receptor alpha (RAR alpha) nuclear immunostaining in gliomas and inability of retinoic acid to influence neural cell adhesion molecule (NCAM) expression.

Authors:  B K Kleinschmidt-DeMasters; E A Orr; E Savelieva; G C Owens; C A Kruse
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Human and rat glioma growth, invasion, and vascularization in a novel chick embryo brain tumor model.

Authors:  Alexandra Cretu; Joseph S Fotos; Brian W Little; Deni S Galileo
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  Protein glycosylation in cancer biology: an overview.

Authors:  F Dall'olio
Journal:  Clin Mol Pathol       Date:  1996-06

4.  Targeting cancer stem cells through L1CAM suppresses glioma growth.

Authors:  Shideng Bao; Qiulian Wu; Zhizhong Li; Sith Sathornsumetee; Hui Wang; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

5.  Integrins mediate adhesion of medulloblastoma cells to tenascin and activate pathways associated with survival and proliferation.

Authors:  Paul Fiorilli; Darren Partridge; Izabela Staniszewska; Jin Y Wang; Maja Grabacka; Kelvin So; Cezary Marcinkiewicz; Krzysztof Reiss; Kamel Khalili; Sidney E Croul
Journal:  Lab Invest       Date:  2008-09-15       Impact factor: 5.662

6.  Physical biology of the cancer cell glycocalyx.

Authors:  Joe Chin-Hun Kuo; Jay G Gandhi; Roseanna N Zia; Matthew J Paszek
Journal:  Nat Phys       Date:  2018-07-04       Impact factor: 20.034

7.  Neuroectodermal tumors of the peripheral and the central nervous system share neuroendocrine N-CAM-related antigens with small cell lung carcinomas.

Authors:  W M Molenaar; L de Leij; J Q Trojanowski
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Differential expression of cell adhesion molecules (CAM), neural CAM and epithelial cadherin in ependymomas and choroid plexus tumors.

Authors:  D Figarella-Branger; H Lepidi; C Poncet; D Gambarelli; N Bianco; G Rougon; J F Pellissier
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Polysialic acid neural cell adhesion molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines.

Authors:  Marie-Claude Amoureux; Béma Coulibaly; Olivier Chinot; Anderson Loundou; Philippe Metellus; Geneviève Rougon; Dominique Figarella-Branger
Journal:  BMC Cancer       Date:  2010-03-10       Impact factor: 4.430

10.  Stimulation of glioma cell motility by expression, proteolysis, and release of the L1 neural cell recognition molecule.

Authors:  Muhua Yang; Shalini Adla; Murali K Temburni; Vivek P Patel; Errin L Lagow; Owen A Brady; Jing Tian; Magdy I Boulos; Deni S Galileo
Journal:  Cancer Cell Int       Date:  2009-10-29       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.